Business
ThermoFisher Salesforce Votes Precipio’s HemeScreen® as “Best New Product”
HemeScreen® Technology and Product Line singled out from thousands of products distributed by Fisher Healthcare at recent National Sales Meeting NEW HAVEN,
About this update from Precipio, Inc.
[{"type":"text","content":"HemeScreen® Technology and Product Line singled out from thousands of products distributed by Fisher Healthcare at recent National Sales Meeting\nNEW HAVEN, Conn., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) was recognized at ThermoFisher’s National Sales Meeting for the development and launch of its HemeScreen® technology. HemeScreen is distributed by Fisher Healthcare, a division of ThermoFisher, to laboratories nationwide. Precipio entered into a distribution agreement with Fisher Healthcare in the latter part of 2022 to distribute its Hemescreen products to laboratories. The salesforce enthusiasm and customer engagement accompanying this award is expected to generate orders from Fisher customers in Q2-2023 and rapidly growing revenues in Q3-2023 and beyond. Of the thousands of products ThermoFisher distributes, Precipio’s HemeScreen was selected as #1 for Best New Product based on various criteria, including: Provides the highest value to customers (clinical impact, workflow simplification, and economic contribution)Represents the highest level of innovation and creativityWill be most attractive to customers and therefore generate significant revenue growth to the sales teamGenerates the most excitement among their sales team “We are privileged to have Fisher Healthcare as a distribution partner, and I am honored that our team and our technology has been recognized by such a market leader”, said Ilan Danieli, Precipio’s CEO. “Our company will continue to be entirely focused on translating this positive energy, enthusiasm, and customer interest into revenue and growth for Fisher and for our company, and to delivering the promise of HemeScreen technology to patients nationwide.” About Precipio Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit...